7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
Meet Veristat at DIA Europe, March 18-20, 2025
Join us at DIA Europe 2025, the largest neutral life sciences conference in the region, where science, innovation, and regulatory experts converge.
Veristat is a global, science-driven CRO and consultancy dedicated to accelerating the development, approval, and commercialization of groundbreaking therapies. With flexible, scalable engagement models for clinical trial planning, execution, regulatory affairs and strategic consulting, we help Sponsors bring life-changing treatments to patients worldwide.
March 18-20, 2025, Congress Center Basel, Switzerland
DIA Europe is the largest neutral life sciences conference in the region, bringing together leaders from science, healthcare, patient advocacy, and regulatory sectors. Veristat experts will be on-site, ready to discuss how Veristat’s tailored solutions can help navigate the complexities of the European market and beyond.
Let’s connect. Schedule a meeting with Veristat today.
Veristat Attendees:
Beatrice Oberle-Rolle – VP Quality Assurance and Pharmacovigilance
Anja Bührer - VP Regulatory Affairs
Conference Details:
Date: March 18-20, 2025
Location: Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland
Schedule a Meeting:
Fill out the form to schedule a meeting with our experts and explore how Veristat can accelerate your clinical trials, regulatory submissions, and market access strategies toward success.
Learn more about the conference
3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...